Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

JACC Debuts Data Digest on CV Health in the United States

News Daily News

JACC Debuts Data Digest on CV Health in the United States

January 12, 2026

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

Pediatric Hypertension On the Rise Globally

News Daily News

Pediatric Hypertension On the Rise Globally

November 28, 2025

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

June 12, 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

Tirzepatide Tops Semaglutide for Weight Loss SURMOUNT-5

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

Top General Cardiology and Prevention News of 2024

News Daily News

Top General Cardiology and Prevention News of 2024

December 30, 2024

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

October 23, 2024

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

News Daily News

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

October 04, 2024

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

News Daily News

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

August 15, 2024

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

News Daily News

‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD

June 27, 2024

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

April 07, 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

April 06, 2024

FDA Grants MACE Reduction Indication for Semaglutide

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

March 08, 2024

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.